Connection
Debopam Samanta to Epilepsies, Myoclonic
This is a "connection" page, showing publications Debopam Samanta has written about Epilepsies, Myoclonic.
|
|
Connection Strength |
|
|
|
|
|
2.359 |
|
|
|
-
Samanta D. Changing Landscape of Dravet Syndrome Management: An Overview. Neuropediatrics. 2020 04; 51(2):135-145.
Score: 0.702
-
Samanta D. Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy. Pediatr Neurol. 2019 07; 96:24-29.
Score: 0.659
-
Samanta D. Sinus pericranii and myoclonic epilepsy: novel features of 3q29 microdeletion syndrome. Acta Neurol Belg. 2016 Sep; 116(3):363-4.
Score: 0.520
-
Samanta D, Ramakrishnaiah R, Willis E, Frye RE. Myoclonic epilepsy evolved into West syndrome: a patient with a novel de novo KCNQ2 mutation. Acta Neurol Belg. 2015 Sep; 115(3):475-8.
Score: 0.478